Skip to main content
. 2017 Aug 8;8(48):83872–83889. doi: 10.18632/oncotarget.20040

Figure 10. KX2-391 inhibits CD31 and VEGF expression in the injured peritoneum.

Figure 10

Peritoneal membrane was collected at 21 days after CG injury with or without administration of KX2-391(KX2) (A–D). Photomicrographs illustrate immunohistochemical staining of CD31 and VEGF (yellow) in the submesothelial compact zone (A, C). The number of CD31-positive vessels (B), or VEGF-positive cells (D) was accounted from 10 random fields (X200) of six rat peritoneal samples. Data are means ± S.E.M. (n = 6). Bars with different letters (a-c) are significantly different from one another (P < 0.05).